Publications
5539 Results
- Journal / Conference
- Proc of the American Society of Clinical Oncology 21:347a(#1386)
- Year
- 2002
- Research Committee(s)
- Melanoma
- Study Number(s)
- S9804
Evaluation of vinorelbine tartrate (navelbine) in patients with dissemminated malignant melanoma and at least one prior systemic therapy, phase II: a Southwest Oncology Group Study
- Journal / Conference
- Proc of the American Society of Clinical Oncology 21:297a(#1184)
- Year
- 2002
- Research Committee(s)
- Lung
- Study Number(s)
- S9914
Southwest Oncology Group Trial (SWOG) 9914: phase II trial of paclitaxel, carboplatin and topotecan (PCT) in untreated patients (pts) with extensive small cell lung cancer (SCLC).
- Journal / Conference
- Proc of the American Society of Clinical Oncology 21:138a(#548)
- Year
- 2002
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S9924
A phase II study of farnesyl transferase inhibitor R115777 in pancreatic cancer. a Southwest Oncology Group (SWOG) study.
- Journal / Conference
- Proc of the American Society of Clinical Oncology 21:294a(#1174)
- Year
- 2002
- Research Committee(s)
- Lung
- Study Number(s)
- S0004
SWOG 0004: pilot study of tirapazamine (TPZ) plus cisplatin/etoposide (PE) and concurrent thoracic radiotherapy (RT) in limited small cell lung cancer (LSCLC).
- Journal / Conference
- Proc of the American Society of Clinical Oncology 21:413a(#1651)
- Year
- 2002
- Research Committee(s)
- Sarcoma
- Study Number(s)
- S0033
Phase III dose-randomized study of Imatinib mesylate (Gleevec, STI571) for GIST: Intergroup S0033 early results
- Journal / Conference
- Journal of Urology 167(4)Suppl:304(#1202)
- Year
- 2002
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8894 (INT-0105) (EST-2889)
Ten-year survival in patients with metastatic (M+) prostate cancer (CAP): analysis of Southwest Oncology Group (SWOG) 8894.
- Journal / Conference
- American Journal of Clinical Pathology 118(4):504-511
- Year
- 2002
- Research Committee(s)
- Melanoma
- Study Number(s)
- SWOG-8049
Risk assessment in localized primary cutaneous melanoma: a Southwest Oncology Group study evaluating nine factors and a test of the Clark logistic regression prediction model.
- Journal / Conference
- Blood 100(12):3869-3876
- Year
- 2002
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-9333
Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group study
- Journal / Conference
- Gynecologic Oncology 84:479(#1)
- Year
- 2002
- Research Committee(s)
- Gynecologic
- Study Number(s)
- S9701
Phase 3 randomized trial of 12 versus 3 months of single-agent paclitaxel in patients with advanced ovarian cancer who attained a clinically defined complete response to platinum/paclitaxel-based chemotherapy, a Southwest Oncology Group trial
- Journal / Conference
- Blood 100(1):29-35
- Year
- 2002
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-9007